nihonkohden

Philosophy & Strategy

Top Message

Left: Hirokazu Ogino,  President and CEO Right: Takashi Tamura,  Representative Director, Exective Operating Officer Left: Hirokazu Ogino, President and CEO
Right: Takashi Tamura, Representative Director, Exective Operating Officer
First we would like to sincerely thank our shareholders for your continued support.
We hereby report the results for FY2016 ended March 31, 2017.
In FY2016, domestic sales increased as the Company reorganized its sales operations in April 2016 to match each hospital market. Consumables and services also contributed to sales increase. Internationally, as the Company strengthened its business structure, sales increased on a comparable basis and decreased on a yen basis due to yen appreciation. As a result, overall sales increased. Operating income decreased due to the appreciation of the yen as well as the increase of SG&A expenses such as R&D costs and personnel expenses.
To realize its long-term vision for 2020, The CHANGE 2020, Nihon Kohden implemented its four-year mid-term business plan, Strong Growth 2017, which was ended March, 31 2017. The Company enhanced its business structure in R&D, production and sales. However, the financial results were below its targets and the improvement of profitability remains as an issue to be solved.
Nihon Kohden set out its new three-year mid-term business plan, TRANSFORM 2020, which starts from FY2017. The Company aims to transform its operations to achieve a highly profitable structure by creating high customer value and improving productivity within the organization.
The full-year dividend for FY2016 was 35 yen per share, in which the interim and the year-end dividends were 17 yen and 18 yen per share.
We deeply appreciate your continued support.